Deepwise Launches Stroke AI Assistant Diagnosis System 3.0 with Follow-up Comparison Function at CMEF

On May 14, the 81st China International Medical Equipment Fair (CMEF) grandly opened at the National Exhibition and Convention Center in Shanghai. The theme of this year’s event is “Intelligence Reshaping the Future.” Amid the vigorous development of digitalization, the application of new-generation information technologies such as AI, 5G, cloud computing, and big data is accelerating the intelligent digital transformation in the healthcare sector, presenting unprecedented opportunities for development.

The 81st China International Medical Equipment Fair (CMEF) Grandly Opens

This exhibition attracted over 7,000 medical device companies from more than 30 countries and regions worldwide to exhibit consecutively; it also drew more than 2,000 academic experts and industry elites, along with 200,000 professional visitors—including government procurement agencies, hospital buyers, distributors, and agents from over 100 countries and regions—who attended for purchasing, networking, and experiential engagement.

Attendees Entering the Exhibition Hall

From systems to applications, from networks to services, DeepWise is building a new ecosystem for smart healthcare. Leveraging cutting-edge technologies, it provides comprehensive solutions for multiple diseases, continuously enhancing product value to meet clinical needs. Numerous industry-leading experts and executives visited the DeepWise booth to learn more about its latest products.

Leaders from the China Association of Medical Equipment Visit the DeepWise Booth

Committee on Radiological Medicine, Chinese People's Liberation Army

Leaders of the China Medical Imaging Integration Alliance Visit the DeepWise Booth

Following the launch of three new products in March, DeepWise officially unveiled its AI-Assisted Diagnostic System for Stroke 3.0 at this exhibition.

DeepWise integrates its R&D and marketing strengths, conducts in-depth research on authoritative guidelines, strictly curates training data to meet the needs of diverse samples, and leverages its proprietary core algorithms to achieve comprehensive analysis of hemorrhagic and ischemic stroke, continuously empowering its products.

In addition to retaining its original superior performance, the new version of the AI system provides parameters related to midline shift in cases of hemorrhagic stroke caused by intracranial hemorrhage, such as the maximum distance of midline displacement and the volume of midline deviation. Furthermore, tailored to clinical application scenarios, it features a follow-up comparison function that conducts multi-angle analysis of changes in hemorrhage volume based on lesion characteristics. For ischemic stroke, the system generates score-based partition pseudo-color maps according to regional segmentation results, assisting physicians in localizing lesions within the scored partitions.

Experience AI, Experience the Extraordinary

DeepWise focuses on key areas in AI-driven healthcare, strategically developing and refining its product portfolio to meet the demands of diverse, differentiated application scenarios. It is committed to delivering leading AI+ healthcare products and solutions for various clinical applications. Centered on smart healthcare, DeepWise has established a comprehensive suite of AI-powered medical products, including the Dr.Wise® AI-assisted medical diagnosis system, which is widely used in early screening for lung cancer and breast cancer, assessment of children’s growth and development, and screening for thoracic diseases.

Dr.Wise®Cloud, the intelligent imaging cloud platform, supports the development of primary care hospitals by leveraging medical consortium models to connect them with tertiary hospitals. This enables physicians to efficiently access medical imaging data and AI processing results across various terminals and locations. Tertiary hospitals can provide precise diagnostic recommendations to primary care facilities, making image interpretation more flexible and efficient.

Dr.Wise® Radiomics Multimodal Research Platform integrates advanced deep learning technologies to streamline the complex workflow of radiomics research, enhance research efficiency, and assist physicians in generating high-impact research outcomes and publications.

Qiao Xin, Co-founder and CEO of DeepWise, stated in an interview at the exhibition booth that China is currently experiencing a favorable period for artificial intelligence development. With strong national support and guidance, AI-driven medical products and markets are gradually becoming more standardized. The annual growth rate of physicians in China is significantly lower than that of medical equipment, a disparity that is particularly pronounced in grassroots healthcare settings.

The integration of artificial intelligence (AI) with the Internet not only alleviates, to some extent, the scarcity of medical resources, reduces burdens, and unleashes traditional medical capacity, but also aligns with national strategies for technological innovation and building a technologically strong nation. Currently, through its “DeepWise Intelligent Imaging Cloud,” DeepWise has achieved numerous success stories in empowering grassroots healthcare. For instance, Qingyuan County Traditional Chinese Medicine Hospital in Zhejiang Province introduced DeepWise’s AI medical products. By locally deploying an AI-assisted diagnostic system and leveraging the connectivity advantages of the Internet, the hospital established an interconnected information platform that bridges upper- and lower-tier hospitals. This initiative facilitates the downward flow of high-quality medical resources, ultimately reducing the number of hospital visits required by patients through intelligent informatization, improving healthcare efficiency, and enhancing public access to medical services. As industry practitioners, our greatest hope is that such technology will benefit more hospitals, making healthcare more accessible.

DeepWise Co-Founder/CEO Qiao Xin Gives Exclusive Interview to Media

Among the ranks of AI development in Chinese medicine, DeepWise has taken a leading position in the industry. To realize its corporate vision of making healthcare more accessible, DeepWise is increasingly integrating advanced AI technologies into its products, driving continuous innovation and securing new competitive advantages for the future.